• Slide

    Bladder Cancer Europe 2017

    27th March 2018, Brussels

  • Slide

    Bladder Cancer Europe 2017

    27th March 2018, Brussels

  • Slide

    Bladder Cancer Europe 2017

    27th March 2018, Brussels

  • Slide

    Bladder Cancer Europe 2017

    27th March 2018, Brussels

  • Slide

    Bladder Cancer Europe 2017

    27th March 2018, Brussels

  • Slide

    Bladder Cancer Europe 2017

    27th March 2018, Brussels

  • Slide

    Bladder Cancer Europe 2017

    27th March 2018, Brussels

Bladder cancer is the 5th most common cancer in the Western world and the 4th most common in men. Despite not being rare, it is hardly ever discussed and is known as ‘the forgotten cancer’.

The majority of diagnoses are in the 60+ age group, but increasingly people of all ages are finding themselves affected.

Most cases appear to be caused by exposure to harmful substances and chemicals, and it is estimated that half of all cases of bladder cancer are caused by smoking.

Prevalence is increasing and this will only place greater burdens on healthcare services and expenditures throughout Europe.

Continued investment in research and innovation is essential for improving diagnostic accuracy and developing novel therapeutic approaches.

The EU must raise greater awareness of bladder cancer through educating, highlighting the risk factors and symptoms and promoting healthier lifestyles as a preventive measure.

This roundtable meeting will bring together EU policy makers, medical and clinical professionals, academic experts, healthcare payers and patient groups, to examine the ongoing challenges in managing bladder cancer more effectively and explore practical solutions in order to reach an EU-wide consensus and implement a forward action plan.

At this roundtable, participants will hear from high level EU health officials and leading oncology experts, offering a variety of perspectives and recommendations through a series of open discussions.

Subjects to be addressed include:
  • Potential for a uniform EU-wide policy
  • Data and information sharing between member states
  • A Patient-Centred Multidisciplinary Approach to Bladder Cancer
  • Accuracy of Current Diagnostic Techniques
  • New Developments in Immunotherapy of Bladder Cancer
  • Bladder Cancer Management in Senior Adults: A Call to Action
  • Holistic Personalised Management to Improve Quality of Life
  • Reaching an EU-Wide Consensus for Improved Diagnostic Accuracy, Effective Management and Care
  • The BCG, Cystectomy, Mitomycin and Photodynamic Therapy
  • Overcoming gender and social class disparities in Bladder Cancer
Networking

The Roundtable will also provide hours of networking time, including coffee breaks, lunch, and a drinks reception to ensure participants have the maximum possible time to establish and stregthen relationships, whilst exchanging ideas.